Diabetes Discourse

Diabetes educators focus on helping patients living with diabetes and related conditions achieve behavior change goals and lead to better clinical outcomes and improved health status. How has the role of the certified diabetes educator changed in the management of diabetes? Join host Dr. Steven Edelman and his guest, diabetes educator at SHARP Healthcare, Angela Norton, as they discuss the benefits and increasing role of the diabetes educator in the management of diabetes.

Gastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.

Initiating insulin therapy for type 2 patients provides its own set of challenges and opportunities. New insulin preparations and a better understanding of insulin physiology may provide physicians more options in effectively tailoring insulin therapy to the needs of their patients. Join host Dr. Steven Edelman and his guest, director of clinical diabetes programs at the University of Southern California, Dr. Anne Peters, as they discuss the benefits of initiating insulin therapy for type 2 patients.

The prevalence of type 2 diabetes increases with age, with an estimated 8.6 million Americans over the age of 60 diagnosed with diabetes, and a growing number at-risk for developing diabetes with age. Our elderly face unique diabetes management challenges. Join host Dr. Steven Edelman and his guest, registered dietitian and Certified Diabetes Educator Janice Baker, as they discuss the unique challenges in caring for our elderly patients with diabetes.

Integrative medicine appears to be an effective approach to the overall management of patients living with diabetes. Host Dr. Steven Edelman's guest, founder and medical director of the Scripps Center for Integrative Medicine in La Jolla, California, Dr. Mimi Guarneri, stresses that the more a patient puts in, the more they get out of an integrative medicine program. They discuss an integrative approach to risk modification and disease management focused on reducing stress, improving emotional state, increasing fitness, maximizing nutrition, and reducing dependence on medications.

Patients with type 2 diabetes struggle to lose or maintain weight, especially with particular therapies. What are some of the successful therapeutic interventions available for overweight patients with type 2 diabetes? What are the potential health effects of the loss of even 5 to 10 pounds for these patients? Join host Dr. Steven Edelman and his guest, director of the Nutrition and Metabolic Research Center and director of the center for Weight Management at the Scripps Clinic in La Jolla, California, Dr. Ken Fujioka, as they discuss the role that weight plays in the aetiology of diabetes and its particular benefits.

Where do thiazolidinediones, or TZD's, fit in our clinical approach to treating patients with type 2 diabetes? TZD's used early in the course of the disease seem to be a powerful therapy with a substantial reduction in the progression of type 2 diabetes. What does this tell us about the pathogenesis of diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine and chief of the division of endocrinology, diabetes and metabolism of the University of Vermont, Dr. Jack Leahy, as they discuss the pathogenesis of diabetes and the role of thiazolidinediones in the prevention and treatment of type 2 diabetes.

Diabetes has moved from being a disease of developed countries to a disease in developing countries such as India and Asia. What are some of the cultural influences surround this growing epidemic? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of Southern California, Dr. Francine Kaufman, as they discuss the new challenges to this growing global epidemic.

Continuous glucose monitoring is an effective tool in the management of both type 1 diabetes and insulin-requiring type 2 diabetes patients. However, barriers and challenges remain for both the healthcare provider and patient. Join host Dr. Steven Edelman and his guest, director of the Advanced Metabolic Care + Research Institute, Dr. Timothy Bailey, as they discuss the benefits of and advances in continuous glucose monitoring.

We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as they discuss the different classes of oral agents, benefits and treatment algorithms in the treatment of type 2 diabetes.